Developmental toxicity of metal chelating agents. (Q52183650)

26 April 2018

review article

1 reference

title

Developmental toxicity of metal chelating agents. (English)

1 reference

26 April 2018

0 references

1

1 reference

26 April 2018

publication date

1 September 1998

1 reference

26 April 2018

published in

Reproductive Toxicology

1 reference

26 April 2018

volume

12

1 reference

26 April 2018

page(s)

499-510

1 reference

26 April 2018

issue

5

1 reference

26 April 2018

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

1 reference

7 January 2021

Treatment of Wilson's disease: the historical background

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

PREVENTION AND TREATMENT OF ALUMINUM TOXICITY INCLUDING CHELATION THERAPY: STATUS AND RESEARCH NEEDS

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Metal-induced developmental toxicity in mammals: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Prevention by chelating agents of metal-induced developmental toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

A critical review of low-level prenatal lead exposure in the human: 1. Effects on the fetus and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

A critical review of low-level prenatal lead exposure in the human: 2. Effects on the developing child

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Unanswered questions in metal chelation

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Therapeutic chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

New developments in therapeutic chelating agents as antidotes for metal poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

A hypothesis for the selection of chelate antidotes for toxic metals

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Antidotes for zinc intoxication in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Relative efficacy of chelating agents on excretion and tissue distribution of manganese in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The Efficacy of DTPA Treatment after Deposition of Thorium Nitrate in the Rat Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Structure-activity relationships among dithiocarbamate antidotes for acute cadmium chloride intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Long-term therapy with deferiprone

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

British anti-lewisite (BAL).

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Treatment of Acute Lead Intoxication — Choice of Chelating Agents and Supportive Therapeutic Measures

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Childhood lead poisoning and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Evaluation of the protective activity of 2,3-dimercaptopropanol and sodium 2,3-dimercaptopropane-1-sulfonate on methylmercury-induced developmental toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

BAL alleviation of arsenate‐induced teratogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Developmental anomalies in mice induced by 2,3‐dimercaptopropanol (BAL)

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Mobilization of heavy metals by newer, therapeutically useful chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

meso-2,3-Dimercaptosuccinic acid and prevention of arsenite embryotoxicity and teratogenicity in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Effects of meso-2,3-dimercaptosuccinic acid (DMSA) on the teratogenicity of sodium arsenate in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Effects of meso-2,3-dimercaptosuccinic acid (DMSA) on methyl mercury-induced teratogenesis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Developmental toxicity of subcutaneously administered meso-2,3-dimercaptosuccinic acid in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Oral meso-2,3-dimercaptosuccinic acid in pregnant Sprague-Dawley rats: teratogenicity and alterations in mineral metabolism. I. Teratological evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Oral meso-2,3-dimercaptosuccinic acid in pregnant Sprague-Dawley rats: teratogenicity and alterations in mineral metabolism. II. Effect on mineral metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Meso-2,3-dimercaptosuccinic acid (DMSA) affects maternal and fetal copper metabolism in Swiss mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Effects of oral meso-2,3-dimercaptosuccinic acid (DMSA) administration on late gestation and postnatal development in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Cadmium Mobilization in Vivo by Intraperitoneal or Oral Administration of Monoalkyl Esters of meso–2, 3–Dmercaptosuccinic Acid in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Developmental toxicity evaluation of monoisoamyl meso-2,3-dimercaptosuccinate in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Evaluation of the developmental toxicity of 2,3-dimercapto-1-propanesulfonate (DMPS) in mice. Effect on mineral metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Evaluation of the developmental effects on mice after prenatal, or pre- and postnatal exposure to 2,3-dimercaptopropane-1-sulfonic acid (DMPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The effects of various chelating agents on the teratogenicity of lead nitrate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Teratogenic effects of a chelating agent and their prevention by zinc

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Use of EDTA to Produce Zinc Deficiency in the Pregnant Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Congenital malformations resulting from zinc deficiency in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Zinc deficiency in the developing rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Zinc deficiency in pregnant Long-Evans hooded rats: teratogenicity and tissue trace elements

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Effect of route of administration on the toxicity and teratogenicity of EDTA in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Teratogenesis studies with EDTA and its salts in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

LEAD POISONING DURING PREGNANCY. FETAL TOLERANCE OF CALCIUM DISODIUM EDETATE.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Congenital lead intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Treatment of acute lead intoxication. A quantitative comparison of a number of chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The removal of strontium from the mouse by chelating agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Influence of several antidotal treatments on the distribution and excretion of strontium

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Ca-DTPA-induced fetal death and malformation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The influence of diethylenetriaminepenta-acetate on the synthesis of DNA, RNA and proteins in the regenerating rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Penicillamine, a new oral therapy for Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Neonatal abnormalities associated with D-penicillamine treatment during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Reversible cutis laxa due to maternal D-penicillamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Teratogen update: penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Teratogenesis and low copper status resulting from D-penicillamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Reduction by copper supplementation of teratogenic effects of D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Pregnancy in Penicillamine-Treated Patients with Wilson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Letter: Pregnancy in penicillamine-treated patients with Wilson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Differential effect of N-acetylcysteine on excretion of the metals Hg, Cd, Pb and Au

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Analysis of protective activity of N-acetylcysteine against teratogenicity of heavy metals

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The protective effects of N-acetyl-L-cysteine against methyl mercury embryotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Prevention by Tiopronin (2-mercaptopropionyl glycine) of methylmercuric chloride-induced teratogenic and fetotoxic effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Prevention by Tiron (sodium 4,5-dihydroxybenzene-1,3-disulfonate) of vanadate-induced developmental toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Effectiveness of sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) in protecting against uranium-induced developmental toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Successful pregnancy in transfusion-dependent thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Fatal iron intoxication in late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

The Consequences of Iron Overdose and its Treatment with Desferrioxamine in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Assessment of the developmental toxicity of deferoxamine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

Altered maternal zinc metabolism following exposure to diverse developmental toxicants

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2898%2900036-7

7 January 2021

10.1016/S0890-6238(98)00036-7

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9763241

1 reference

26 April 2018